Perimenopause Depression & Anxiety: Treatable | ScienceWorks

Last reviewed: 06/06/2026

Reviewed by: Dr. Kiesa Kelly

Somewhere in your 40s, the ground can shift. Maybe a flat, joyless heaviness has crept in where there used to be interest. Maybe you wake at 3 a.m. with your heart racing for no reason, or you feel a flash of rage at something small and barely recognize yourself. And maybe everyone — including you — has chalked it up to stress, aging, or "just hormones." Here is what the research says clearly: perimenopause is a real window of increased vulnerability to depression and anxiety, and what you are feeling may be a treatable disorder, not a personal failing or an inevitable part of getting older.

This article is for the woman in midlife who is struggling with her mood and is not sure whether to take it seriously. You do not need an ADHD or autism frame for this to apply to you. You just need to know that midlife mood changes are real, they are studied, and they respond to treatment.

In this article, you'll learn:

• Why perimenopause is a genuine window of vulnerability for depression and anxiety

• What the major studies (SWAN and the Penn Ovarian Aging Study) actually found

• What it feels like — and how it overlaps with, and differs from, brain fog

• Why it happens, at the level of estrogen and brain chemistry

• What helps, including where hormone therapy fits and where it does not

• When to get evaluated, and how to sort mood from thyroid and other causes

The tension this post resolves is the one that keeps many women from getting help: Is this something I should just push through, or is it something a clinician can actually treat? The evidence is firmly on the side of treatable.

Yes, perimenopause can cause real depression and anxiety

Perimenopause — the transition leading up to your final period, which can last several years — is associated with a measurable increase in the risk of depression and anxiety [1][2]. This is not a fringe claim or a wellness-industry talking point; it comes from large, long-running studies that followed women through the transition. If your symptoms have lasted more than two weeks and are affecting your life, a depression screening is a reasonable first concrete step, and it applies to you just as much as it would to anyone else.

This is not "just stress" or "just hormones"

Misconception: midlife mood changes are just stress and you should push through. In reality, the menopausal transition is an independent biological risk factor for depression, over and above the life stressors that happen to cluster in midlife [1][2]. Researchers controlled for those stressors and still found elevated risk. Naming it as "just stress" can keep you from getting effective treatment for something that responds well to it.

Why the transition is a genuine window of vulnerability

The hormonal turbulence of perimenopause — not the eventual low-estrogen state, but the erratic, unpredictable swings on the way there — appears to be what destabilizes mood for vulnerable women [2][3]. This is a recognized phenomenon, sometimes compared to the heightened sensitivity some women experience premenstrually or postpartum, when hormones are also shifting rapidly. The instability, not a single hormone level, is the issue.

Key takeaway: 🌗 Perimenopause is a window of vulnerability driven by hormonal fluctuation, not just decline — and the mood changes it brings are real and treatable.

What the research shows

The SWAN findings — increased odds of depression in perimenopause

The Study of Women's Health Across the Nation (SWAN) followed thousands of women through the menopausal transition. It found that the odds of clinically significant depressive symptoms were significantly higher during perimenopause and early postmenopause than during premenopause — on the order of roughly one and a half times the odds or more, with the highest risk in late perimenopause [1][4]. Importantly, this held even after accounting for demographic, psychosocial, and health factors, which is what makes the menopausal-transition effect credible rather than a byproduct of midlife stress.

New-onset depression with no prior history

The most striking evidence comes from the Penn Ovarian Aging Study, which followed women who had no history of depression at all when they enrolled. Among these previously-never-depressed women, entering perimenopause was associated with about 2.5 times the odds of developing diagnosable major depression and more than four times the odds of clinically significant depressive symptoms, compared with remaining premenopausal [5]. In other words, perimenopause can bring a first-ever depressive episode in a woman with no prior vulnerability — which is exactly why "but I've never been depressed before" is not a reason to dismiss what you are feeling.

Who is most at risk

Some women are more vulnerable than others. The strongest single risk factor is a prior history of depression, which sharply raises the odds of depressive symptoms during the transition [5]. Other recognized risk factors include a history of PMDD or postpartum depression, severe vasomotor symptoms (hot flashes and night sweats), disrupted sleep, and significant life stress [2][3]. If several of these describe you, it is worth watching your mood closely and seeking help early. A history of mood symptoms tied to hormonal shifts is a thread worth pulling, and a psychological evaluation can help connect it.

Key takeaway: 📊 In women with no prior depression, perimenopause was linked to roughly 2.5x the odds of major depression. A first episode in midlife is real, not imagined.

What it actually feels like

Depression that looks like flatness, irritability, or loss of interest

Perimenopausal depression does not always look like classic sadness. For many women it shows up as a flatness — a loss of interest and pleasure in things that used to matter, a sense of going through the motions [3][6]. Consider a recognizable scenario: you still get up, get the kids out the door, and do your job, but the color has drained out of it. You used to love your Saturday morning run and your book club; now they feel like chores, and you cancel more than you go. You are not crying all the time — you are just somewhere far away from your own life, and it has been months.

Anxiety, "menopause rage," and the 3 a.m. wakeups

The other common face is anxiety. Or: you are lying awake at 3 a.m., heart pounding, running through a list of worries that feel enormous in the dark and faintly ridiculous by morning. During the day, a small frustration — a slow website, a misplaced set of keys — triggers a surge of anger that feels bigger than the moment and leaves you ashamed afterward. This "menopause rage" is a recognizable presentation of the irritability and anxiety that the hormonal transition can amplify [2][3], and a brief anxiety screen can help you see how much of your experience it accounts for.

How it overlaps with — and differs from — brain fog

Many women in perimenopause also notice cognitive changes — the word-finding pauses, the walking-into-a-room-and-forgetting moments often called "brain fog." It is worth being clear about how this relates to mood. Brain fog and depression overlap: depression itself impairs concentration and memory, so some of the fog may be the depression. But cognitive changes can also occur somewhat independently in the transition. The practical point is that if low mood and anxiety are present alongside the fog, treating the mood often lifts a meaningful part of the cognitive cloud too — which is a reason to take the mood seriously rather than focusing only on the memory lapses.

Misconception: brain fog in midlife means early dementia. In reality, perimenopausal cognitive changes are usually a feature of the transition and are frequently entangled with mood and sleep — not a sign of a degenerative disease. Persistent or worsening cognitive decline still deserves evaluation, but the common midlife fog is far more often hormonal and mood-related.

Why it happens

Estrogen's effect on serotonin and dopamine

Estrogen is not only a reproductive hormone; it is an active modulator of the brain's mood chemistry. It influences serotonin and dopamine signaling — the same systems most antidepressants target [3][7]. When estrogen fluctuates erratically and then declines through perimenopause, that modulation becomes unstable, which can destabilize mood. Declining estrogen has also been linked to greater reactivity of the body's stress-response (HPA) axis, which is closely tied to depression [3][7].

Progesterone, allopregnanolone, and GABA

Progesterone matters too. Its metabolite allopregnanolone acts on GABA receptors — the brain's main calming system — and the withdrawal and fluctuation of these neurosteroids across the transition can heighten anxiety and emotional reactivity in sensitive women [7]. This is the same family of mechanisms implicated in premenstrual and postpartum mood changes, which is part of why women with those histories are more vulnerable in perimenopause.

The biopsychosocial load of midlife

Biology does not act in a vacuum. Perimenopause typically lands in a life stage crowded with demands — aging parents, teenagers, career pressure, disrupted sleep, and shifting identity. These do not cause the elevated biological risk, but they interact with it [2][3]. Honoring both halves — the real neurobiology and the real life circumstances — is what good treatment does.

Key takeaway: 🔬 Fluctuating estrogen destabilizes serotonin and dopamine signaling; shifting neurosteroids affect GABA. The biology is real and it interacts with midlife stress.

What helps

Therapy and what it targets

For both depression and anxiety in perimenopause, psychotherapy is a first-line, evidence-based option. Cognitive behavioral therapy and acceptance and commitment therapy help with the rumination, the sleep disruption, and the catastrophic 3 a.m. thinking, and they carry no medication side effects [6][8]. Therapy is often where our specialized therapy work begins for midlife mood changes, because it addresses both the symptoms and the life context they are unfolding in.

When antidepressants are appropriate

For moderate-to-severe depression or anxiety, antidepressants (typically SSRIs or SNRIs) are a standard, well-established treatment, and some also reduce hot flashes — a useful two-for-one in perimenopause [6][8]. The evidence for antidepressants in menopause-related mood symptoms is real if modest, and they are frequently combined with therapy for a stronger effect. The right choice depends on severity, your history, and your preferences, and it is a conversation worth having in detail with a clinician.

Where hormone therapy fits — and where it does not

This is the part where it is most important to be precise. Hormone therapy is the most effective treatment for the physical symptoms of menopause, and a body of research suggests that estrogen may improve mood for some women in perimenopause [9][10]. But hormone therapy is not considered a first-line treatment for depression or anxiety [9][10]. For a diagnosable mood disorder, standard treatments — therapy and antidepressants — come first. Hormone therapy may be considered as an addition in specific situations: for example, when prominent hot flashes and night sweats are disrupting sleep and feeding the mood symptoms, or when a woman has only partially responded to antidepressants. That decision is individualized, made with a prescribing clinician who weighs your full medical picture — not a substitute for mental health treatment.

Misconception: if hormones are the cause, hormone therapy must be the cure. In reality, the most effective treatments for perimenopausal depression are the same evidence-based mental health treatments used for depression generally; hormone therapy plays a supporting role in select cases, not a primary one.

Key takeaway: 🧭 Therapy and antidepressants are first-line for perimenopausal depression and anxiety. Hormone therapy helps physical symptoms and can support mood in select cases — but it is not a stand-alone treatment for a mood disorder.

When to get evaluated

Sorting mood, cognition, and thyroid

Several conditions can masquerade as — or coexist with — perimenopausal depression, and a good evaluation sorts them out. Thyroid disorders, anemia, vitamin deficiencies, and sleep disorders can all produce fatigue, low mood, and fog, and they become more common in midlife. This is why a thorough assessment looks beyond a single explanation. If your picture is layered — mood plus cognition plus physical symptoms — our mental health screening and assessment process is built to help separate the threads and point you toward the right kind of help.

Safety thresholds

One situation should never wait. If you are having thoughts of harming yourself, or your symptoms feel unbearable or dangerous, please reach out right away — call or text the 988 Suicide and Crisis Lifeline, or contact a clinician now rather than waiting to see whether it passes. Midlife depression can be severe, and severe depression is a medical situation that deserves immediate support.

A simple decision heuristic

If you want a rule of thumb: if low mood, loss of interest, or anxiety has lasted more than two weeks and is interfering with your work, relationships, or daily life, treat it as a treatable condition and seek an evaluation — regardless of your age, your hormone status, or whether you've ever felt this way before. Do not require yourself to first prove it is "really" depression versus "just menopause." That sorting is the clinician's job, and the treatments overlap. The threshold for getting help is impairment and duration, not certainty about the cause.

Navigating a women's-health or hormonal change?

Hannah Pollok works at the intersection of physical and mental health — hormones, reproductive changes, and the mood and cognitive shifts that come with them.

Meet Hannah Pollok →

Frequently Asked Questions

Is it depression or just menopause?

It can be both, and the distinction matters less than getting help. Perimenopause is a genuine window of increased vulnerability to depression and anxiety, so new or worsening mood symptoms in your 40s or 50s are not something to wait out. If low mood, loss of interest, or anxiety has persisted for two weeks or more and is affecting your life, it deserves evaluation regardless of what is driving it.

Will perimenopause depression go away after menopause?

For some people mood stabilizes once hormone levels settle in postmenopause, but the risk of depressive symptoms remains elevated into early postmenopause, and depression is not something to simply wait out. Effective treatments exist now. If symptoms are interfering with your life, treating them rather than waiting for menopause to finish is both safer and more humane.

Can hormone therapy fix depression in perimenopause?

Hormone therapy is not a first-line treatment for depression. It is the most effective treatment for physical menopause symptoms like hot flashes, and some research suggests estrogen may help mood for certain women in perimenopause. But for diagnosable depression, standard treatments — therapy and antidepressants — come first, with hormone therapy considered as an addition in specific situations a clinician evaluates individually.

Do I need medication, or is therapy enough for perimenopause anxiety?

It depends on severity, and many people do well with therapy alone. Cognitive behavioral therapy has good evidence for both depression and anxiety and carries no medication side effects. For moderate-to-severe symptoms, combining therapy with an antidepressant is often more effective than either alone. A clinician can help you weigh the options based on how much the symptoms are affecting your daily life.

Who is most at risk for depression during perimenopause?

The strongest risk factor is a prior history of depression, which sharply raises the odds of depressive symptoms during the transition. Other risk factors include a history of PMDD or postpartum depression, severe hot flashes and night sweats, disrupted sleep, and significant life stress. If several of these apply to you, it is worth watching your mood closely and seeking help early rather than waiting.

About the Author

Dr. Kiesa Kelly is a licensed clinical psychologist and the founder of ScienceWorks Behavioral Healthcare, with more than 20 years of experience in psychological assessment and evidence-based treatment. Her clinical work includes mood and anxiety conditions across the lifespan, with particular attention to the hormonally-linked presentations — premenstrual, postpartum, and perimenopausal — that are frequently overlooked or misattributed in adult women.

Dr. Kelly's approach emphasizes careful, individualized evaluation and a collaborative, telehealth-forward model of care serving clients across Tennessee. Every article published here is reviewed by a licensed clinician for accuracy before it goes live.

References

1. Bromberger JT, et al. Depressive symptoms during the menopausal transition: The Study of Women's Health Across the Nation (SWAN). 2007. https://pmc.ncbi.nlm.nih.gov/articles/PMC2048765/

2. Bromberger JT, Kravitz HM. Mood and Menopause: Findings from the Study of Women's Health Across the Nation (SWAN) over 10 Years. 2011. https://pubmed.ncbi.nlm.nih.gov/21961723/

3. Associations Between Menopause and Depression: Current Evidence to Guide Practice, Policy, and Research. Journal of Obstetric, Gynecologic & Neonatal Nursing. 2024. https://www.jognn.org/article/S0884-2175(24)00349-6/fulltext

4. The risk of depression in the menopausal stages: A systematic review and meta-analysis. Journal of Affective Disorders. 2024. https://www.sciencedirect.com/science/article/pii/S0165032724006438

5. Freeman EW, et al. Penn Ovarian Aging Study — new onset of depression in women with no prior history during the menopausal transition. 2006 (as reviewed in Associations Between Menopause and Depression, JOGNN 2024). https://www.jognn.org/article/S0884-2175(24)00349-6/fulltext

6. Depression or Menopause? Presentation and Management of Major Depressive Disorder in Perimenopausal and Postmenopausal Women. Primary Care Companion for CNS Disorders. https://www.psychiatrist.com/pcc/depression-menopause-presentation-management-major/

7. Hormonal Agents for the Treatment of Depression Associated with the Menopause. 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9355926/

8. A Primer on Menopausal Hormone Therapy for Mental Health Providers. MGH Center for Women's Mental Health. https://womensmentalhealth.org/posts/menopausal-hormone-therapy-for-mental-health-providers/

9. The Menopause Society. Hormone therapy and mood: current evidence and guidance. https://menopause.org/press-releases/feeling-depressed-as-a-result-of-menopause-hormone-therapy-may-help

10. Exploring the Feasibility of Estrogen Replacement Therapy as a Treatment for Perimenopausal Depression: A Comprehensive Literature Review. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11279181/

Disclaimer

This article is for informational and educational purposes only and is not a substitute for professional medical or mental health advice, diagnosis, or treatment. Decisions about antidepressants or hormone therapy should be made with a qualified clinician who knows your full medical history. Always seek the advice of your physician or another qualified health provider with any questions regarding a medical or psychological condition. If you are experiencing thoughts of self-harm or suicide, call or text the 988 Suicide and Crisis Lifeline (in the United States) or go to your nearest emergency room.